The results showed that all four HNSCC cell lines showed a dramatic drop in EGF-induced EGFR phosphorylation when treated with cetuximab (phosphorylations on Tyr845, Tyr1173, and Ser1070 were the strongest without cetuximab treatment) (Figure 2B). Here, EGFR is linked to head and neck squamous cell carcinoma.